Back

Antigen-driven PD1+Tox+Eomes+ and PD1+Tox+BHLHE40+ synovial T lymphocytes regulate chronic inflammation in situ

Maschmeyer, P.; Heinz, G. A.; Skopnik, C.; Lutter, L.; Mazzoni, A.; Heinrich, F.; von Stuckrad, S. L.; Wirth, L. E.; Tran, C. L.; Riedel, R.; Lehmann, K.; Sakwa, I.; Cimaz, R.; Giudici, F.; Mall, M. A.; Enghard, P.; Vastert, B.; Chang, H.-D.; Durek, P.; Annunziato, F.; van Wijk, F.; Radbruch, A.; Kallinich, T.; Mashreghi, M.-F.

2019-12-28 immunology
10.1101/2019.12.27.884098 bioRxiv
Show abstract

Introduction/AbstractT lymphocytes accumulate in inflamed tissues of patients with chronic inflammatory diseases (CIDs) and express pro-inflammatory cytokines upon re-stimulation in vitro1-29. Further, a significant genetic linkage to MHC genes suggests that T lymphocytes play an important role in the pathogenesis of CIDs including juvenile idiopathic arthritis (JIA)30-33. However, the functions of T lymphocytes in established disease remain elusive. Here we dissect the heterogeneity of synovial T lymphocytes in JIA patients by single cell RNA-sequencing. We identify subpopulations of T lymphocytes expressing genes reflecting recent activation by antigen in situ. A PD-1+TOX+EOMES+ population of CD4+ T lymphocytes expressed immune regulatory genes and chemoattractant genes for myeloid cells. A PD-1+TOX+BHLHE40+ population of CD4+, and a mirror population of CD8+ T lymphocytes expressed genes driving inflammation, and genes supporting B lymphocyte activation. This analysis points out that multiple types of T lymphocytes have to be targeted for therapeutic regeneration of tolerance in arthritis.

Matching journals

The top 4 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.